The suspended testing of a leading experimental coronavirus vaccine in Britain is unlikely to affect Hong Kong’s procurement plans for shots, as many other candidates were in the final clinical phase, according to a government health adviser.Professor David Hui Shu-cheong of Chinese University noted that the vaccine being developed by AstraZeneca in partnership with Oxford University was just one of nine in late-stage trials.“It’s always common to have some problems during phase three clinical…
↧